STOCK TITAN

Agenus Inc (AGEN) awards 50,000 stock options to director Thomas L. Harrison

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AGENUS INC director Thomas L. Harrison received a grant of 50,000 Stock Options on August 5, 2026. The options have an exercise price of $7.78 per share, are exercisable for Common Stock, and expire on August 5, 2036. They vest over three years, with one-third vesting on the first anniversary of the grant date and the remaining two-thirds vesting in two equal annual installments thereafter. Following this award, Harrison holds 50,000 options directly.

Positive

  • None.

Negative

  • None.
Insider HARRISON THOMAS L
Role Director
Type Security Shares Price Value
Grant/Award Stock Option F1 50,000 $0.00 $0.00
Holdings After Transaction: Stock Option — 50,000 shares (Direct)
Footnotes (1)
  1. F1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
Options granted 50,000 options Stock Option grant to director Thomas L. Harrison on August 5, 2026
Exercise price $7.78 per share Exercise price of Stock Options for Agenus Inc. Common Stock
Expiration date August 5, 2036 Option expiration date for the 50,000 Stock Options granted
Underlying shares 50,000 shares Common Stock underlying the Stock Options granted to Harrison
Vesting period 3 years One-third after one year, remaining two-thirds in two equal annual installments
Stock Option financial
"The reporting person received a grant of 50,000 Stock Option awards."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"The options have an exercise price of $7.78 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Equity Incentive Plan financial
"Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vesting financial
"and vest over three (3) years, with one-third (1/3) vesting on the first anniversary"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

What did AGEN (AGENUS INC) director Thomas L. Harrison receive in this Form 4 filing?

Thomas L. Harrison received a grant of 50,000 Stock Options on August 5, 2026. These options relate to Agenus Inc. Common Stock and represent a compensation award rather than an open-market purchase or sale.

What is the exercise price of the new stock options reported for AGEN director Harrison?

The Stock Options granted to Harrison have an exercise price of $7.78 per share. This is the price at which he may purchase Agenus Inc. Common Stock upon exercising the options during their term.

How do the AGEN (AGENUS INC) stock options granted to Harrison vest?

The options vest over three years. One-third vests on the first anniversary of the grant date, and the remaining two-thirds vest in two equal annual installments over the following two years, subject to the plan’s terms.

When do Thomas L. Harrison’s AGEN stock options expire?

The Stock Options granted to Harrison expire on August 5, 2036. After this date, any unexercised portion of the 50,000 options can no longer be used to purchase Agenus Inc. Common Stock.

How many Agenus Inc. options does Harrison hold after this Form 4 transaction?

Following this grant, Harrison holds 50,000 Stock Options directly. The Form 4 shows these as his total derivative holdings after the reported transaction, all tied to Agenus Inc. Common Stock.

Under which plan were the AGEN stock options for Harrison awarded and what is its nature?

The options were awarded under the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. This plan provides equity-based compensation, including stock options, that typically vest over time to align director incentives with shareholders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HARRISON THOMAS L

(Last)(First)(Middle)
C/O AGENUS INC.
3 FORBES ROAD

(Street)
LEXINGTON MASSACHUSETTS 02421

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AGENUS INC [ AGEN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option$7.7808/05/2026A50,000 (1)08/05/2036Common Stock50,000$0.0050,000D
Explanation of Responses:
1. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vest over three (3) years, with one-third (1/3) vesting on the first anniversary of the Grant Date and the remaining two-thirds (2/3) vesting in two equal annual installments thereafter.
/s/Melissa Orilall as Attorney-in-Fact for Thomas Harrison08/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)